Stebėti
Jeffrey Willis
Pavadinimas
Cituota
Cituota
Metai
Deep learning algorithm predicts diabetic retinopathy progression in individual patients
F Arcadu, F Benmansour, A Maunz, J Willis, Z Haskova, M Prunotto
NPJ digital medicine 2 (1), 92, 2019
2412019
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two …
CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ...
The Lancet 399 (10326), 741-755, 2022
2282022
Characterizing disease burden and progression of geographic atrophy secondary to age-related macular degeneration
U Chakravarthy, CC Bailey, RL Johnston, M McKibbin, RS Khan, ...
Ophthalmology 125 (6), 842-849, 2018
1942018
The prevalence of concurrent hearing and vision impairment in the United States
BK Swenor, PY Ramulu, JR Willis, D Friedman, FR Lin
JAMA internal medicine 173 (4), 312-313, 2013
1842013
Vision-related functional burden of diabetic retinopathy across severity levels in the United States
JR Willis, QV Doan, M Gleeson, Z Haskova, P Ramulu, L Morse, ...
JAMA ophthalmology 135 (9), 926-932, 2017
1422017
Progression from early/intermediate to advanced forms of age-related macular degeneration in a large UK cohort: rates and risk factors
U Chakravarthy, CC Bailey, PH Scanlon, M McKibbin, RS Khan, ...
Ophthalmology Retina 4 (7), 662-672, 2020
1412020
Gender differences in perception and care-seeking for illness of newborns in rural Uttar Pradesh, India
JR Willis, V Kumar, S Mohanty, P Singh, V Singh, AH Baqui, S Awasthi, ...
Journal of health, population, and nutrition 27 (1), 62, 2009
1302009
Visual impairment, uncorrected refractive error, and accelerometer-defined physical activity in the United States
JR Willis, JL Jefferys, S Vitale, PY Ramulu
Archives of ophthalmology 130 (3), 329-335, 2012
1152012
Visual field loss and accelerometer-measured physical activity in the United States
SW Van Landingham, JR Willis, S Vitale, PY Ramulu
Ophthalmology 119 (12), 2486-2492, 2012
992012
Visual impairment, uncorrected refractive error, and objectively measured balance in the United States
JR Willis, SE Vitale, Y Agrawal, PY Ramulu
JAMA ophthalmology 131 (8), 1049-1056, 2013
732013
Deep learning predicts OCT measures of diabetic macular thickening from color fundus photographs
F Arcadu, F Benmansour, A Maunz, J Michon, Z Haskova, D McClintock, ...
Investigative ophthalmology & visual science 60 (4), 852-857, 2019
672019
The prevalence of myopic choroidal neovascularization in the United States: analysis of the IRIS® data registry and NHANES
JR Willis, S Vitale, L Morse, DW Parke II, WL Rich, F Lum, RA Cantrell
Ophthalmology 123 (8), 1771-1782, 2016
592016
The cost-effectiveness of a child nutrition education programme in Peru
HR Waters, ME Penny, HM Creed-Kanashiro, RC Robert, R Narro, J Willis, ...
Health Policy and Planning 21 (4), 257-264, 2006
532006
Treatment patterns for diabetic macular edema: an intelligent research in sight (IRIS®) registry analysis
RA Cantrell, F Lum, Y Chia, LS Morse, WL Rich, CA Salman, JR Willis
Ophthalmology 127 (3), 427-429, 2020
382020
Treatment patterns for myopic choroidal neovascularization in the United States: analysis of the IRIS registry
J Willis, L Morse, S Vitale, DW Parke II, WL Rich, F Lum, RA Cantrell
Ophthalmology 124 (7), 935-943, 2017
322017
Determination of extended-interval gentamicin dosing for neonatal patients in developing countries
GL Darmstadt, MM Hossain, AK Jana, SK Saha, Y Choi, S Sridhar, ...
The Pediatric infectious disease journal 26 (6), 501-507, 2007
322007
Development of deep learning models to predict best-corrected visual acuity from optical coherence tomography
MG Kawczynski, T Bengtsson, J Dai, JJ Hopkins, SS Gao, JR Willis
Translational vision science & technology 9 (2), 51-51, 2020
282020
Disrupting the ventral premotor cortex interferes with the contribution of action observation to use-dependent plasticity
G Cantarero, JM Galea, L Ajagbe, R Salas, J Willis, P Celnik
Journal of cognitive neuroscience 23 (12), 3757-3766, 2011
242011
TENAYA and LUCERNE: rationale and design for the phase 3 clinical trials of faricimab for neovascular age-related macular degeneration
AM Khanani, RH Guymer, K Basu, H Boston, JS Heier, JF Korobelnik, ...
Ophthalmology Science 1 (4), 100076, 2021
232021
YOSEMITE and RHINE: phase 3 randomized clinical trials of faricimab for diabetic macular edema: study design and rationale
N Eter, RP Singh, F Abreu, K Asik, K Basu, C Baumal, A Chang, KG Csaky, ...
Ophthalmology Science 2 (1), 100111, 2022
212022
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–20